SK Biopharmaceuticals Co., Ltd.

326030.KS · Moat type: REGULIERUNG

MoatScore

8/10

Fair Value

95,963 KRW (≈ 67.17 USD)

Margin of Safety

+18.5 %

Rating

BEOBACHTEN

GESCHÄFTSMODELL SK Biopharmaceuticals develops and markets central nervous system-active pharmaceuticals, particularly antiepileptic drugs, and generates revenues primarily through license fees, milestone payments, and direct product distribution of its own approved active substances.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.